Diabetes and obesity can fuel the relapse of liver cancer -- the sixth most common cancer worldwide, according to a study.
The
study led by Osaka Metropolitan University, focussed on hepatocellular
carcinoma (HCC) -- a type of liver cancer associated with hepatitis infections
-- known to have a high recurrence rate after cancer removal. It is also the
third leading cause of cancer-related deaths globally.
Obesity
and diabetes, which are closely associated with metabolic syndrome development,
are well known to induce steatotic liver diseases, potentially causing liver
cirrhosis and HCC development.
However,
obesity and diabetes' effects on patient survival and cancer recurrence have
been unclear.
"Because
the risk of late recurrence is higher in hepatocellular carcinoma with comorbid
obesity and diabetes, controlling obesity and diabetes is an important
treatment strategy for the liver cancer," said Dr. Hiroji Shinkawa's
research team at the University's Graduate School of Medicine.
In the
study, published in the journal Liver Cancer, the team analysed the
relationship between diabetes mellitus, obesity, and postoperative outcomes in
1,644 patients with hepatocellular carcinoma who underwent liver resection.
The
results revealed that obesity increased the risk of recurrence two years after
the operation approximately by 1.5 times, and in the case of diabetes, the risk
was 1.3 times higher.
In
addition, the risk of recurrence after five years postoperatively was 3.8 times
higher with obesity, while with diabetes it was 2 times higher.
The
findings can contribute to the early detection of cancer recurrence and the
design of appropriate treatment strategies, Shinkawa said.
Obesity
is a common risk factor for type 2 diabetes, and the two conditions are often
linked.
Recent
research showed that the number of adults with obesity will increase by six
times in the next 40 years, while people with diabetes will soar 642 million by
2040.
No comments:
Post a Comment